GENERAL ATLANTIC, L.P.

Holdings History for AKERO THERAPEUTICS, INC. - Common Stock (AKRO)

Symbol: AKRO
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 6,796,489 shares
Security Ownership %: 8.4%

Shares, Excluding Options vs Price

Value, Excluding Options

General Atlantic, L.P. ownership in AKERO THERAPEUTICS, INC. Common Stock (AKRO)

15 May 2025 - General Atlantic, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,796,489 shares of AKERO THERAPEUTICS, INC. Common Stock (AKRO). This represents 8.4% ownership of the company. This is the first filing by GENERAL ATLANTIC, L.P. disclosing ownership of AKERO THERAPEUTICS, INC. Common Stock (AKRO).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
General Atlantic, L.P.	8.4%		$278,656,049	6,796,489			$41.00	13G/A	31 Mar 2025	15 May 2025, 08:13

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-8.2%	$0	0	-5,733,989	-100%	$40.63	Q4 2025
30 Sep 2025	8.2%	0%	$272,249,798	5,733,989	0		$47.48	Q3 2025
30 Jun 2025	8.4%	+0.74%	$305,965,653	5,733,989	+500,000	+9.6%	$53.36	Q2 2025
31 Mar 2025	7.1%	0%	$211,871,875	5,233,989	0		$40.48	Q1 2025
31 Dec 2024	5.2%	0%	$145,609,574	5,233,989	0		$27.82	Q4 2024
30 Sep 2024	4.3%	0%	$150,163,144	5,233,989	0		$28.69	Q3 2024
30 Jun 2024	3.9%	0%	$122,789,382	5,233,989	0		$23.46	Q2 2024
31 Mar 2024	3.1%	+2%	$132,210,562	5,233,989	+3,448,275	+193%	$25.26	Q1 2024
31 Dec 2023	0.6%	0%	$41,696,422	1,785,714	0		$23.35	Q4 2023
30 Sep 2023	1.4%	0%	$90,321,414	1,785,714	0		$50.58	Q3 2023
30 Jun 2023	1.3%	+1.3%	$83,374,987	1,785,714	+1,785,714	NEW	$46.69	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.